tweetindex

Novartis

@Novartis · Basel, Switzerland · joined 07 Nov 2008

An innovative medicines company working to reimagine medicine. See our community guidelines: https://t.co/wolzG1zLye

287 083Followers
512Following
13 252Posts total
17.4KViews on collected posts

Against accounts of the same size

3 posts from the last 90 days, next to the 100K–1M follower range. below its peers on both reach and engagement.

Median views4 132this account22 159median for 100K–1M
Reach, %1.44%this account6.71%median for 100K–1M
Engagement, %0.41%this account1.18%median for 100K–1M
MetricThis accountMedian for 100K–1MRatio
Median views per post4 13222 1590.19×
Reach (views ÷ followers)1.44%6.71%0.21×
Engagement rate0.41%1.18%0.35×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.6K28 Apr
4.2K
2.2K20 Jul
4.2K21 Jul
4.1K

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.31%28 Apr
0.78%
0.53%20 Jul
0.26%21 Jul
0.41%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.18%.

What the audience does

Likes68.6%59 in total
Reposts4.7%4 in total
Replies20.9%18 in total
Bookmarks5.8%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

#Investors: Novartis delivered a solid second quarter, returning to sales growth driven by continued momentum from priority brands. We remain on track to deliver our full-year guidance and mid-term outlook.* Press release: https://t.co/AWqyHGRWD3 Webcast: https://t.co/knc 4.1K views · 12 likes · 1 reposts · 4 replies 21 Jul 2026 #NVSQ226 Novartis social media posts on Q2 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ226 Novartis social media posts on Q2 4.2K views · 9 likes · 1 reposts · 1 replies 21 Jul 2026 On Tuesday, July 21, Novartis will announce its Q2 2026 results. Register to listen here: https://t.co/LIilPfqDRK #NovartisNews $NVS $NOVN #NVSQ226 https://t.co/sqBEM4SRYE 2.2K views · 11 likes · 0 reposts · 1 replies 20 Jul 2026 #Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: https://t.co/c3x8o96Gsf IR Webcast: https://t.co/u5UJ 4.2K views · 22 likes · 2 reposts · 9 replies 28 Apr 2026 #NVSQ126 Novartis social media posts on Q1 2026 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information. #NVSQ126 Novartis social media posts on Q1 2.6K views · 5 likes · 0 reposts · 3 replies 28 Apr 2026

Similar accounts